VEGF Gene Variants and Chronic Inflammation | Decoding Inflammation

By Alberto Rivera, MD · 2026-06-27 · 5 min read

The Angiogenic Switch in Chronic Disease

Vascular Endothelial Growth Factor (VEGF) is primarily recognized for its fundamental role in vasculogenesis and angiogenesis. However, in the field of clinical immunology and "Geneflammation," we must recognize VEGF as a potent pro-inflammatory mediator. In chronic inflammatory states, the "angiogenic switch" is permanently turned on, leading to pathological angiogenesis. This process creates a network of immature, highly permeable vessels that act as a primary conduit for the persistent recruitment of inflammatory cells into target tissues. This isn't just a byproduct of inflammation; it is a central mechanism that sustains the disease state.

The -2578C/A Polymorphism: Driving Hyperexpression

The -2578C/A variant (rs699947) is located within the promoter region of the VEGFA gene, a critical area for regulating how much protein is produced. Carrying the 'C' allele is frequently associated with increased promoter activity and higher circulating levels of VEGF. From a clinical perspective, we see this manifest in patients with rheumatoid arthritis (RA) and psoriasis. In RA, the excess VEGF drives the growth of the pannus—a thick layer of vascularized tissue that invades and destroys bone and cartilage. The -2578C/A polymorphism essentially lowers the threshold for this destructive vascular remodeling to occur.

The -634G/C Variant and Systemic Inflammation

Another critical polymorphism is the -634G/C (rs2010963) variant, situated in the 5'-untranslated region (5'-UTR). This specific location influences the efficiency of protein translation and secretion. The 'C' allele of -634G/C is strongly linked to elevated VEGF protein expression. When combined with other risk factors, this polymorphism accelerates the progression of vascular complications in inflammatory diseases. It is particularly relevant in the study of diabetic retinopathy and atherosclerosis, where the formation of fragile, new blood vessels leads to hemorrhage, plaque instability, and acute cardiovascular events.

The Feed-Forward Loop of Inflammation

The relationship between VEGF and inflammation is bidirectional. Pro-inflammatory cytokines like TNF-alpha and IL-6 stimulate the production of VEGF, which in turn increases vascular permeability. This "leaky" vasculature allows for more cytokines and immune cells to enter the tissue, creating a vicious feed-forward loop. By identifying patients with the -2578C/A and -634G/C variants, we can identify individuals who are genetically predisposed to a more "vascularized" and aggressive inflammatory course.

Clinical Implications for Geneflammation

For the clinician, these genetic insights move us toward personalized medicine. Patients with these high-expression VEGF variants may require more aggressive early intervention or may be candidates for therapeutic strategies that target the angiogenic pathway alongside standard anti-inflammatory treatments. Understanding the genetic architecture of the vascular response is a key component in decoding the complexities of chronic inflammation.